Impact Factor
4.19
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
6.60
1,681 total citations
h5-index
69
h5 depth signal
Cited share
72.0%
201 of 279
Total citations
1,681
Citation footprint
Metric signal
6.67
External metric anchor
Self-citation
1.1%
18 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Sweden
546
United States
344
United Kingdom
178
Italy
150
Germany
118
Citing Fields of Research
Cardiology
260
Diabetes
142
Immunology
121
Hematology
116
Virology
104
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
6,342
Articles tracked across the journal lifetime
Indexed publication set
279
201 cited publications
Last 12 months
142
11.8 publications/month
Open access share
67.6%
96 OA publications in the last year
Leading citing country
Sweden
546 citing publications
Leading citing field
Cardiology
260 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v225n1, Jan. 1989-
v225n1, Jan. 1989-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Auto-Inflammatory Disorders
Kidney Diseases
Neurodegenerative Disorders
Hematology
Diabetes
Liver Diseases
Broad Categories
Internal Medicine
Urology
Hematology
Musculoskeletal Disorders
Cardiology
Virology
Diabetes
Auto-Inflammatory Disorders
MeSH Descriptors
Internal Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1111/joim.70173
Open DOI
Treatment of hyperphagia and obesity in Prader–Willi syndrome
Prader–Willi syndrome (PWS) is a rare, neurodevelopmental, multisystemic syndrome caused by lack of expression of paternal genes on chromosome 15q11.2–13. PWS is characterized by muscular hypotonia, abnormal body composition, hormone def...
02
DOI 10.1111/joim.70170
Open DOI
GLP‐1 receptor agonists and serious adverse events: Evidence, uncertainty and clinical implications
Glucagon‐like peptide‐1 (GLP‐1) receptor agonists provide benefits in weight reduction, glycaemic control in Type 2 diabetes, and cardiovascular and renal outcomes. Their widespread use has given rise to concerns regarding rare but poten...
03
DOI 10.1111/joim.70166
Open DOI
Employment status and occupation are associated with liver cirrhosis: A nationwide Swedish case–control study
Background: Liver cirrhosis is often diagnosed in working‐age adults and carries a poor prognosis. A better understanding of variation by employment status and occupation may support earlier and more targeted diagnostic evaluation. Objec...
04
DOI 10.1111/joim.70167
Open DOI
High urine osmolality and elevated urine sodium predict early nonresponse to fluid restriction in patients with the syndrome of inappropriate antidiuresis
Introduction: Fluid restriction is the current first‐line therapy for hyponatremia induced by the syndrome of inappropriate antidiuresis (SIAD), yet up to 50% of patients do not achieve an adequate plasma sodium correction. Reported pred...
05
06
DOI 10.1111/joim.70168
Open DOI
Issue Information
07
DOI 10.1111/joim.70165
Open DOI
Vascular Ehlers–Danlos syndrome: A multidisciplinary clinical framework for early suspicion, emergency‐safe management and lifelong care
Vascular Ehlers–Danlos syndrome (vEDS), caused by likely pathogenic COL3A1 variants, carries a high risk of arterial dissection or rupture, intestinal perforation and uterine rupture, and a median survival near 51 years. It is often reco...
08
DOI 10.1111/joim.70164
Open DOI
Routine versus standardized blood pressure measurements: Agreement and association with cardiovascular disease
Background: Recommendations for blood pressure (BP) measurement are poorly followed in clinical practice, possibly leading to inaccurate BP estimates. Objectives: To assess the agreement between routine and standardized BPs, and the asso...
09
DOI 10.1111/joim.70161
Open DOI
Cancer co‐medication quality in older patients with polypharmacy: A large randomized trial testing a medication review versus usual care
Background: Evidence from randomized controlled trials (RCTs) testing medication reviews in geriatric oncology is sparse. Methods: We conducted a single‐blinded RCT in ten rehabilitation clinics across Germany. Patients with common cance...
10
DOI 10.1111/joim.70151
Open DOI
A demographic perspective on longevity and healthspan: Rethinking population ageing through a positive and prospective lens
Population ageing is portrayed as a threat to the sustainability of health and welfare systems. This narrative—grounded in static chronological definitions of old age—risks overstating the burden of increasing longevity while overlooking...
Bibliographical & Catalog Notes
Title from cover.
Prior to 2001, supplement treated as a separate publication. Supplement ceased with issue 741 (Feb. 2001).
Each year consists of two volumes of six numbers each.
Also issued online.
Vol. 225, no. 1 (JAN 1989)19911012 Notice not published Printed on acid-free paper